Abstract
Purpose: Our purpose was to evaluate the relationship between the initial follicle count during gonadotropin stimulation after gonadotropin-releasing hormone (GnRH) agonist suppression and the efficiency of controlled ovarian hyperstimulation (COH) in patients receiving treatment with assisted reproductive technologies (ARTs).
Methods: A total of 338 COH procedures in 291 couples was performed with cycles that reached the stage of oocyte retrieval. The ovarian antral follicle number was measured using transvaginal ultrasonography at the folliculometry during gonadotropin stimulation by GnRH agonist suppression in patients undergoing ARTs. Controlled ovarian hyperstimulation was accomplished using GnRH agonist down-regulation combined with FSH and menotropin stimulation. The characteristics of oocytes after retrieval and embryos after in vitro culture and the pregnancy rates were assessed.
Results: The procedures performed included 195 ET cycles, 129 TET cycles, and 14 incomplete cycles. The treatment cycles were divided into four categories according to the antral follicle number (i.e., ≤5, 6–10, 11–15, and ≥16) at the first folliculometry to evaluate the influence of various factors. The antral follicle count correlated significantly with the patient age, dosage of gonadotropins, serum estradiol concentration, number of antral follicles (≥13 mm) while receiving hCG injections, number of oocytes retrieved, and, later, number of embryos transferred. There was a trend toward an increasing number of pregnancies per cycle as the number of antral follicles increased (14.7, 26.5, 44, and 45%, respectively).
Conclusions: We were able to predict the efficiency of COH and outcome of ARTs based on the follicle count during the first folliculometry during gonadotropin stimulation after GnRH agonist suppression. The results of the folliculometry significantly predicted the ovarian response to COH and the outcome of ARTs in the current treatment cycle.
Similar content being viewed by others
REFERENCES
Scott RT Jr, Hofmann GE: Prognostic assessment of ovarian reserve. Fertil Steril 1995;63:1-11
Wallach EE: Pitfalls in evaluating ovarian reserve. Fertil Steril 1995;63:12-14
Gosden RG: Maternal age: A major factor affecting the prospects and outcome of pregnancy. Ann NY Acad Sci 1985;442:45-57
Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z: Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51:651-654
Toner JP, Philput CB, Jones GS, Muasher SJ: Basal folliclestimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784-791
Hansen LM, Batzer FR, Gutmann JN, Corson SL, Kelly MP, Gocial B: Evaluating ovarian reserve: Follicle stimulating hormone and oestradiol variability during cycle days 2-5. Hum Reprod 1996;11:486-489
Licciardi FL, Liu H-C, Rosenwaks Z: Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 1995;64:991-994
Smotrich DB, Widra EA, Gindoff PR, Levy MJ, Hall JL, Stillman RJ: Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 1995;64:1136-1140
Loumaye E, Billion J-M, Mine J-M, Psalti 1, Pensis M, Thomas K: Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril 1990;53:295-301
Tanbo T, Dale PO, Lunde O, Norma N, Abyholm T: Prediction of response to controlled ovarian hyperstimulation: A comparison of basal and clomiphene citrate-stimulated folliclestimulating hormone levels. Fertil Steril 1992;57:819-824
Winslow KL, Toner JP, Brzyski RG, Oehninger SC, Acosta AA, Muasher SJ: The gonadotropin-releasing hormone agonist stimulation test: A sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril 1991;56:711-717
Fanchin R, de Ziegler D, Olivennes F, Taieb J, Dzik A, Frydman R: Exogenous follicle stimulating ovarian reserve test (EFORT): A simple and reliable screening test for detecting ‘poor responders’ in in-vitro fertilization. Hum Reprod 1994;9:1607-1611
Chang SY, Lee CL, Wang ML, Hu ML, Lai YM, Chang MY, Soong YK: No detrimental effect in delaying initiation of gonadotropin administration after pituitary desensitization with GnRH-a. Fertil Steril 1993;59:183-186
World Health Organization: WHO Laboratory Manual for Examination Semen and Sperm-Cervical Mucus Interaction, 3rd ed. Cambridge, Cambridge University Press, 1992
Kruger TF, Menkveld R, Stander FS, Lombard CJ, Van der Merwe JP, Van Zyl JA, Smith K: Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertil Steril 1986;46:1118-1123
Huang FJ, Chang SY, Tsai MY, Lin YC, Kung FT, Lin YC, Wu JF, Lu YJ: Relationship of the human cumulus-free oocyte maturational profile with in vitro outcome parameters after intracytoplasmic sperm injection. J Assist Reprod Genet 1999;16(9):209-211
Tsai MY, Huang FJ, Kung FT, Lin YC, Chang SY, Wu JF, Chang HW: The influence of polyvinylpyrrolidone on the outcome of intracytoplasmic sperm injection. J Reprod Med 2000;45(2):115-120
Toth TL, Hodgen GD: Ovarian follicular growth and maturation. In Reproductive Medicine and Surgery, EE Wallach, HA Zacury (eds). St. Louis, CV Mosby, 1995, pp 137-157
McNatty K: Ovarian follicular development from the onset of luteal regression in human and sheep. In Follicular Maturation and Ovulation, R Rolland, EV van Hall, SG Hillier, KP McNatty, J Schoemaker (eds). Amsterdam, Excerpta Medica, 1982, pp 1-18
Goodman AL, Hodgen GD: The ovarian triad of the primate menstrual cycle. Recent Prog Horm Res 1983;39:1
Kerin J, Edmonds D, Warnes G, et al.: Morphological and functional relations of Graafian follicle growth to ovulation in women using ultrasonic, laparoscopic, and biochemical measurements. Br J Obstet Gynaecol 1981;88:81-90
Brown JB: Pituitary control of ovarian function: Concepts derived from gonadotropin therapy. Aust NZ J Obstet Gynaecol 1978;18:46-54
Schoemaker J, van Weissenbruch MM, Scheele F, van der Meer M: The FSH threshold concept in clinical ovulation induction. Balliere Clin Obstet Gynecol 1993;7:297-308
Lolis DE, Tsolas O, Messinis IE: The follicle-stimulating hormone threshold level for follicle maturation in superovulated cycles. Fertil Steril 1995;63:1272-1277
Schipper I, Hop WCJ, Fauser BCJM: The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: Duration, rather than magnitude, of FSH increase affects follicle development. J Clin Endocrinol Metab 1998;83:1292-1298
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Huang, FJ., Chang, SY., Tsai, MY. et al. CLINICAL ASSISTED REPRODUCTION: Determination of the Efficiency of Controlled Ovarian Hyperstimulation in the Gonadotropin-Releasing Hormone Agonist-Suppression Cycle Using the Initial Follicle Count During Gonadotropin Stimulation. J Assist Reprod Genet 18, 91–96 (2001). https://doi.org/10.1023/A:1026582608645
Issue Date:
DOI: https://doi.org/10.1023/A:1026582608645